4.4 Article

Molecular characterisation of carbapenem-resistant Pseudomonas aeruginosa clinical isolates in Nepal

期刊

JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE
卷 26, 期 -, 页码 279-284

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.jgar.2021.07.003

关键词

Pseudomonas aeruginosa; Carbapenemase; 16S rRNA methylase; Carbapenem resistance

资金

  1. Japan Society for the Promotion of Science [18K07120]
  2. Research Program on Emerging and Re-emerging Infectious Diseases from the Japan Agency for Medical Research and Development [21fk0108604h0701]
  3. Grants-in-Aid for Scientific Research [18K07120] Funding Source: KAKEN

向作者/读者索取更多资源

This study aimed to determine the genetic and epidemiological properties of carbapenem-resistant Pseudomonas aeruginosa strains isolated from hospitals in Nepal. The findings revealed that these strains carried various carbapenemase and 16S rRNA methylase genes, belonging to different sequence types. These results suggest the spread of carbapenem-resistant P. aeruginosa in medical settings in Nepal.
Objectives: The emergence of carbapenem-resistant Pseudomonas aeruginosa has become a serious worldwide medical problem. The aim of this study was to determine the genetic and epidemiological properties of carbapenem-resistant P. aeruginosa strains isolated from hospitals in Nepal. Methods: A total of 43 carbapenem-resistant P. aeruginosa isolates obtained from patients in two hospitals in Nepal between 2018 and 2020 were analysed. Their whole genomes were sequenced by nextgeneration sequencing. A phylogenetic tree was constructed from single nucleotide polymorphism (SNP) concatemers. Multilocus sequence typing (MLST) was performed and antimicrobial resistance genes were identified. Results: Of the 43 isolates, 17 harboured genes encoding carbapenemases, including IMP-1, IMP-26, KPC2, NDM-1, VIM-2 and VIM-5, and 12 harboured genes encoding 16S rRNA methylases, including RmtB4 and RmtF2. The carbapenem-resistant P. aeruginosa isolated in Nepal belonged to various sequence types (STs), including ST235 (5 isolates), ST244 (7 isolates), ST274 (1 isolate), ST357 (10 isolates), ST654 (3 isolates), ST664 (1 isolate), ST773 (1 isolate), ST823 (3 isolates), ST1047 (8 isolates), ST1203 (2 isolates) and ST3453 (2 isolates). Conclusion: To the best of our knowledge, this is the first molecular epidemiological analysis of carbapenem-resistant P. aeruginosa clinical isolates from Nepal. The findings strongly suggest that P. aeruginosa isolates producing carbapenemases and 16S rRNA methylases have spread throughout medical settings in Nepal. (c) 2021 The Authors. Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy. This is an open access article under the CC BY license ( http://creativecommons.org/licenses/by/4.0/ )

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据